Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.20
-0.15 (-0.38%)
Apr 29, 2026, 1:23 PM CST
7.69%
Market Cap 1.65B
Revenue (ttm) 220.40M
Net Income (ttm) 58.93M
Shares Out 42.00M
EPS (ttm) 1.40
PE Ratio 28.11
Forward PE n/a
Dividend 1.00 (2.54%)
Ex-Dividend Date Apr 9, 2026
Volume 8,007
Average Volume 90,983
Open 39.10
Previous Close 39.35
Day's Range 39.10 - 39.20
52-Week Range 35.55 - 80.40
Beta 0.58
RSI 41.41
Earnings Date May 5, 2026

About Taiwan Biomaterial

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1921
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6649
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.